TIBO derivatives: a new class of highly potent and specific inhibitors of HIV-1 replication.
Pauwels
R
R
Rega Institute for Medical Research, Katholieke Universiteit Leuven, Belgium.
Andries
K
K
Debyser
Z
Z
Kukla
M
M
Schols
D
D
Desmyter
J
J
De Clercq
E
E
Janssen
P A
PA
D000998:Antiviral Agents / Q000494:pharmacology*; D001569:Benzodiazepines / Q000494:pharmacology*; D002460:Cell Line; D054303:HIV Reverse Transcriptase; D015497:HIV-1 / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology*; D015394:Molecular Structure; D018894:Reverse Transcriptase Inhibitors; D013329:Structure-Activity Relationship; D014779:Virus Replication / Q000187:drug effects*
D000998:Antiviral Agents; D007093:Imidazoles; D018894:Reverse Transcriptase Inhibitors; D001569:Benzodiazepines; C067413:R-82913; D054303:HIV Reverse Transcriptase